BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25486383)

  • 1. Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012).
    Balda MV; Garay OU; Papale RM; Bignone I; Bologna VG; Brandolini A; Prokopez CR; Balasini JI; Baldessarini RJ; Daray FM
    Int Clin Psychopharmacol; 2015 Mar; 30(2):109-14. PubMed ID: 25486383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematological adverse events in clozapine-treated children and adolescents.
    Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
    J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
    Maskasame S; Krisanaprakornkit T; Khiewyoo J
    J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine-induced agranulocytosis and leukopenia: Incidence, associated factors, and rate of hematologic adverse-effects monitoring in psychiatric out-patient services in Thailand.
    Tunsirimas N; Pariwatcharakul P; Choovanichvong S; Ratta-Apha W
    Asian J Psychiatr; 2019 Mar; 41():13-16. PubMed ID: 30856469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
    Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J
    J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
    Schulte P
    Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-Associated Leukopenia and Agranulocytosis in Western Cape, South Africa: A 3-Year Retrospective Cohort Study.
    Geldenhuys C; Zunza M; Tiffin N; Koen L; Decloedt EH
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):250-254. PubMed ID: 33843819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine treatment in Australia: a review of haematological monitoring.
    Copolov DL; Bell WR; Benson WJ; Keks NA; Strazzeri DC; Johnson GF
    Med J Aust; 1998 May; 168(10):495-7. PubMed ID: 9631674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted.
    Lahdelma L; Appelberg B
    J Clin Psychiatry; 2012 Jun; 73(6):837-42. PubMed ID: 22480452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL; Yim PH
    East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
    Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A
    Vertex; 2011; 22(96):94-7. PubMed ID: 21977603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agranulocytosis and significant leucopenia with neuroleptic drugs: results from the AMUP program.
    Grohmann R; Schmidt LG; Spiess-Kiefer C; Rüther E
    Psychopharmacology (Berl); 1989; 99 Suppl():S109-12. PubMed ID: 2573103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
    Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
    Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haematological side effects of clozapine: patient characteristics.
    Miller PR; Cutten AE
    N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J; Berdichevsky E; Conte G; Tellez C
    Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.